SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001172661-24-000547
Filing Date
2024-02-08
Accepted
2024-02-08 12:29:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 laurion-plrx123123.htm SC 13G 99666
  Complete submission text file 0001172661-24-000547.txt   101250
Mailing Address 360 MADISON AVENUE SUITE 2000 NEW YORK NY 10017
Business Address 360 MADISON AVENUE SUITE 2000 NEW YORK NY 10017 212-938-6325
Laurion Capital Management LP (Filed by) CIK: 0001390202 (see all company filings)

IRS No.: 562504425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Subject) CIK: 0001746473 (see all company filings)

IRS No.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91525 | Film No.: 24607891
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)